Ankylosing Spondylitis: Genetic Factors and Quality of Life

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on genetics & health. Browse all Genetics & Health education

Ankylosing spondylitis (AS) is a form of inflammatory arthritis that primarily affects the spine and the sacroiliac joints where the spine meets the pelvis. Chronic inflammation can cause pain and stiffness and, over time, may lead to fusion of spinal segments that limits mobility. Because AS often begins in early adulthood and follows a lifelong course, understanding its genetic factors — and the evidence-based habits that support quality of life — matters a great deal.

Genetics is central to AS. It is one of the most strongly heritable common rheumatic conditions, and a handful of genes explain much of that inherited risk. Knowing them helps clarify why the condition runs in families, though genetic context never replaces evaluation and care from a qualified provider.

HLA-B27: The Dominant Genetic Factor

The single most important gene in ankylosing spondylitis is HLA-B27, part of the human leukocyte antigen system that helps the immune system distinguish the body's own cells from invaders. The overwhelming majority of people with AS carry HLA-B27. Importantly, the reverse is not true: most people who carry HLA-B27 never develop AS. The gene raises susceptibility substantially but is neither necessary nor sufficient on its own — a clear example of genetics as a guide, not a verdict.

ERAP1 and IL23R: Shaping the Immune Response

Beyond HLA-B27, the ERAP1 gene modifies risk in an interesting way: its effect appears mainly in people who are also HLA-B27 positive. ERAP1 trims protein fragments that HLA molecules display to the immune system, so variants can change which peptides are presented — a plausible mechanistic link to the inflammation seen in AS.

The IL23R gene sits in the interleukin-23 pathway, a signaling route central to the type of immune activation involved in spondyloarthritis. Variants in IL23R are associated with AS risk and help explain why this pathway has become a major focus of rheumatology research. Together, HLA-B27, ERAP1, and IL23R illustrate how several genes converge on immune regulation.

Recognizing the Condition

Hallmark features of AS include inflammatory back pain that improves with movement and worsens with rest, morning stiffness lasting more than 30 minutes, and gradual onset before age 45. AS can also involve the eyes (uveitis), and less commonly the heart and lungs. Because early symptoms overlap with ordinary back pain, diagnosis is frequently delayed — which is why persistent, characteristic symptoms deserve a rheumatology evaluation rather than self-assessment.

Evidence-Based Ways to Support Quality of Life

Quality of life in AS is strongly influenced by consistent, provider-guided habits. Regular physical activity and structured exercise — particularly movement that preserves posture, flexibility, and core strength — is among the most consistently supported strategies in the research. Physical therapy can tailor a program to your spine.

Not smoking is especially important, as smoking is associated with worse outcomes and faster progression. Good sleep, stress management, and staying engaged with a rheumatologist for monitoring round out a well-rounded approach. These are general, evidence-based measures that support daily function; they are not a cure, and any medication decisions belong to your provider.

What Pathway-Level Genetics Reveals

The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, providing pathway-level context about your biology across immune, inflammatory, and metabolic pathways. It does not diagnose, treat, manage, or predict ankylosing spondylitis, and it is not a substitute for HLA-B27 testing or rheumatology care. What it offers is education — a factual read on aspects of your genetics that you can bring into an informed conversation with a qualified provider.

Frequently Asked Questions

Does carrying HLA-B27 mean I will develop ankylosing spondylitis?

No. Most people who carry HLA-B27 never develop ankylosing spondylitis. The gene substantially raises susceptibility but is neither necessary nor sufficient on its own. Other genes, environmental factors, and chance all contribute, so HLA-B27 status is a risk marker, not a diagnosis or a certainty.

Can a genetic test diagnose ankylosing spondylitis?

No. A genetic test provides pathway-level context about your biology, not a diagnosis. Ankylosing spondylitis is diagnosed by a rheumatologist using symptoms, exam, imaging, and labs. Genetics can describe inherited tendencies but cannot confirm, rule out, treat, or manage the condition on its own.

What lifestyle habits support quality of life with AS?

Research consistently supports regular exercise that preserves posture and flexibility, physical therapy, not smoking, good sleep, and stress management. Staying engaged with a rheumatologist for monitoring is key. These general measures support daily function and comfort but are not a cure, and medication decisions belong to your provider.

Which genes besides HLA-B27 are involved?

ERAP1 and IL23R are two of the most studied. ERAP1 influences which protein fragments the immune system displays, and its effect is strongest in HLA-B27 carriers. IL23R sits in the interleukin-23 immune-signaling pathway. Both help explain the inflammatory biology behind ankylosing spondylitis alongside HLA-B27.

Want pathway-level context on your immune and inflammatory genetics? Take the Precision Peptide Genetic Test to explore your pathway-level genetics and bring that context to your next provider conversation.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

This article is part of the PlexusDx Education Hub. Browse all Genetics & Health education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.